Back
to sessions
Sep 28
Scientific
MODERATOR(S)
Kenneth Rosenzweig, MD, FASTRO - Icahn School of Medicine at Mount Sinai
Farzan Siddiqui, MD, PhD, MBA, FASTRO - Henry Ford Hospital/Wayne State University
Credits
| AMA PRA Category 1 Credits: | 1.50 |
Presentations
-
01:30pm - 01:39pm ET
Hypofractionated vs. Conventional Fractionated Postmastectomy Radiotherapy in High-Risk Breast Cancer: 10-Year Outcomes from a Phase 3 Randomized Trial
Speaker: Guang-Yi Sun, MD - National Cancer Center/Cancer Hospital, Chinese Academy of Medical Science and Peking Union Medical, Beijing -
01:39pm - 01:43pm ETSpeaker: Janice Lyons, MD, FASTRO - University Hospitals - Seidman Cancer Center, Cleveland
-
01:43pm - 01:47pm ETSpeaker: Michelle Specht, MD - ,
-
01:47pm - 01:56pm ET
Initial Results of NRG Oncology NRG-GI003: A Phase III Randomized Trial of Protons vs. Photons for Hepatocellular Carcinoma (HCC)
Speaker: Theodore Hong, MD - Dana-Farber Cancer Institute, Boston -
01:56pm - 02:00pm ETSpeaker: Erqi Pollom, MD, MS - Stanford Cancer Institute Palo Alto, Stanford
-
02:00pm - 02:04pm ETSpeaker: Marco Schwarz, PhD - Department of Radiation Oncology, University of Washington, Seattle
-
02:04pm - 02:13pm ET
Alliance A071801 Phase III Trial Postoperative Single Fraction Stereotactic Radiosurgery (SRS) vs. Fractionated SRS (fSRS) for Resected Brain Metastasis
Speaker: Ayal Aizer, MD - Brigham and Women's Hospital, Boston -
02:13pm - 02:17pm ETSpeaker: Rupesh Kotecha, MD - Miami Cancer Institute, Miami
-
02:17pm - 02:21pm ETSpeaker: Roshan Prabhu, MD, MS - Atrium Health Levine Cancer, CHARLOTTE
-
02:21pm - 02:30pm ET
NRG-CC009: A Phase III Trial of Stereotactic Radiosurgery (SRS) vs. Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) for Brain Metastases from Small Cell Lung Cancer (SCLC)
Speaker: Chad Rusthoven, MD - University of Colorado School of Medicine, Aurora -
02:30pm - 02:34pm ETSpeaker: Henning Willers, MD, FASTRO - Massachusetts General Hospital, Boston
-
02:34pm - 02:38pm ETSpeaker: Debra Yeboa, MD - MD Anderson Cancer Center, Houston
-
02:38pm - 02:42pm ET
Efficacy of Radical Prostatectomy Versus Stereotactic Body Radiotherapy (SBRT) for Localised Prostate Cancer: Results from an international Phase III Randomised Controlled Trial (PACE - A)
Speaker: Nicholas van As, MD, MB - The Royal Marsden NHS Foundation Trust, London -
02:42pm - 02:48pm ETSpeaker: Deborah Citrin, MD, FASTRO - NIH/NCI, Bethesda